NCT Number: NCT04118309
The Effects of High-intensity Interval Training on Mental Health and Inflammation
The present study investigated the effects of high-intensity interval exercise training and placebo-exercise on mental health and inflammation using a randomized control trial. The study also examined how anxiety symptoms prior to high-intensity interval training may influence improvements in fitness. Inactive young adults underwent nine weeks of either high-intensity interval training or their regular routine. Questionnaires, a blood draw and a maximal exercise test were conducted the week before and week after the intervention. It was hypothesized those who underwent high-intensity interval training would experience greater reductions in their depression, anxiety, and inflammation than those who were in the placebo control group. It was also hypothesized those who had high anxiety symptoms at the start of high-intensity interval training would experience smaller improvements in fitness than those who had low anxiety symptoms.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year–30 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Who can participate
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Full-time student at McMaster University
- Speak, read and understand English
Exclusion criteria
- Exercising for more than 150 minutes of moderate-to-vigorous physical activity per week
Treatment and study plan
Placebo
OtherPrimary outcomes
-
Change in mental illness symptoms (anxiety, depression) from baseline to post-intervention
Time frame: 11 weeks
The 21-items of the Beck Anxiety Inventory (Beck, Brown, Epstein & Steer, 1998) are summed to produce a total score from 0-63, with a higher score reflecting more severe anxiety symptoms. The 21-items of the Beck Depression Inventory (Beck, Steer, & Brown, 1996) are summed to produce a total score from 0-63, with a higher score reflecting more severe depressive symptoms.
-
Change in concentration of circulating proinflammatory cytokines (Interleukin-6, Interleukin-1 beta, Tumour necrosis factor alpha) from baseline to post-intervention
Time frame: 11 weeks
Picogram measured from venous blood sample
-
Change in cardiorespiratory fitness from baseline to post-intervention
Time frame: 11 weeks
VO2peak test (ml/min/kg)
Sponsors and collaborators
Lead sponsor
McMaster University
Other
Collaborators
- Natural Sciences and Engineering Research Council, Canada
Registry information
Important dates
- Study start
- 2015
- Primary completion
- 2016
- Study completion
- 2016
- First posted
- Oct 8, 2019
- Registry last updated
- Oct 8, 2019
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Aging and Reward System Response to Inflammation and Anxiety Study
NCT05363527
Aging, Anhedonia
Los Angeles, California, United States
View Trial DetailsResources, Inspiration, Support and Empowerment (RISE) for Black Pregnant Women
NCT05552053
Anxiety, Anxiety Disorders
Los Angeles, California, United States
View Trial DetailsWellness App for Sleep Disturbance in Hematological Cancer Patients
NCT05294991
Anxiety, Anxiety Disorders
Phoenix, Arizona, United States
View Trial DetailsDepressive Symptoms After Cardiac Surgery
NCT06706323
Anxiety, Anxiety Disorders
Zurich, Switzerland
View Trial Details